Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Ocular GVHD
Interventions: Tacrolimus, Methylprednisolone Sodium Succinate; Drug
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injury, Ambulation Difficulty, Muscle Spasticity
Interventions: Exoskeleton-Assisted Walking, Transcutaneous Lumbosacral Stimulation (TLS); Device
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: PD - Parkinson's Disease
Interventions: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001); Combination Product
Lead sponsor: University of California, San Diego; Other
Eligibility: 40 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Post-Traumatic Stress Disorder
Interventions: Active stimulation, Sham stimulation, Virtual Reality (VR); Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Suicide
Interventions: ACT for Life, Present Centered Therapy; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 278 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • Battle Creek, Michigan

Conditions: Opioid Use
Interventions: Prescription Opioid Management App; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Multiple Sclerosis, Spasticity
Interventions: Dry needling, Sham dry needling; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cocaine Use Disorder (CUD)
Interventions: Low Intensity Focused Ultrasound; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Orthopedic Surgery, General Anesthesia
Interventions: vitalHEAT vH2 Temperature Management System, Arizant Healthcare Bair Hugger Temperature Management System; Device
Lead sponsor: Dynatherm Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Social Skills, Emotional Dysfunction
Interventions: mindfulness, emotion didactics, interpersonal skills, experiential learning; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Sunscreening Agent
Interventions: BAY987517, Sunscreen Lotion (RB# T78-190B); Drug
Lead sponsor: Bayer; Industry
Eligibility: 3 Years to 9 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: TVS, SHAM; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Restless Legs Syndrome
Interventions: Rotigotine 1 milligram/24 hours, Rotigotine 2 milligram/24 hours, Placebo; Drug
Lead sponsor: UCB Biopharma SRL; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Culver City, California

Conditions: Tinea Pedis, Tinea Cruris
Interventions: Omeprazole 40 mg, Luliconazole Cream 1%; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Post Operative Pain Management
Interventions: Scopolamine Patch (Transderm V); Drug
Lead sponsor: Alexander M Spiess, MD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 74 participants
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Overweight and Obesity, Metabolic Syndrome, Weight Loss
Interventions: Signos System, Standard Lifestyle Education; Device · Other
Lead sponsor: Signos Inc; Industry
Eligibility: 22 Years and older
Enrollment: 380 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Phoenix, Arizona • Walnut Creek, California • North Miami, Florida + 2 more

Conditions: Catheter-related Bloodstream Infection
Interventions: Chlorhexidine-impregnated foam dressing; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 1,088 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cardiovascular Health, Self-management
Interventions: Health360x plus health coach, Health360x only (High tech); Behavioral
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 21 Years to 70 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Second Hand Tobacco Smoke, Nicotine Dependence
Interventions: Ask, Advise, Refer, Telebased tobacco counseling, Telebased nutrition counseling, Mobile phone smoking cessation application, Mobile phone nutrition application, Nicotine polacrilex; Behavioral · Device · Drug
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Breast Cancer Locator (BCL); Device
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Opioid-use Disorder, Opioid Withdrawal
Interventions: Sparrow Ascent Therapy System, Lofexidine, Extended-release injectable naltrexone; Device · Drug
Lead sponsor: Spark Biomedical, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Rancho Mirage, California • Crownsville, Maryland • Center City, Minnesota + 1 more

Conditions: Staphylococcal Skin Infections, Abscesses, Furunculosis, Staphylococcus Aureus, MRSA Infection
Interventions: 2% Mupirocin Ointment, 4% Chlorhexidine liquid soap, Hygiene protocol; Drug · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Months to 21 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 1 Diabetes
Interventions: Type 1 Doing Well (T1DW) Program, Diabetes-Related Information and Resources Program; Behavioral · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 10 Years to 99 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Opioid Misuse
Interventions: CPMRx; Behavioral
Lead sponsor: Jessica Morgan; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

Exoskeleton and Spinal Cord Stimulation for SCI

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

tDCS Plus Virtual Reality for PTSD

Testing the Efficacy of ACT for Life

Mobile Health (mHealth) App for Safe Opioid Use

Dry Needling in Multiple Sclerosis

Low Intensity Focused Ultrasound in Cocaine Use Disorder

Comparison Study of Intraoperative Patient Warming Systems

Feasibility and Acceptability Off The Equus Effect

Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old

Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

Using Signos mHealth Platform in Adults for Weight Management

Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)

MECA Clinical Intervention ( MECA Health360x)

Babies Living Safe and Smokefree

A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

Staphylococcus Aureus Decolonization Study

EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes

Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section